Background and objectives: Follow-up studies of children and young adults born very-
Although recent data suggest that the halted alveolarization of the preterm lung has the ability to catch-up throughout childhood, followup studies of children and young adults born very-to-moderately preterm show persistent and significant lung function deficits. [9] [10] [11] In a population-based study of extremely preterm survivors born below 26 weeks of gestation in 1995, a large proportion suffered from lung function deficits still 11 years after birth: 56% percent had abnormal spirometry and 25% had a current diagnosis of asthma. 12 Studies reporting from more contemporary cohorts of children born very preterm suggests that significant impairments in lung structure and lung function still are major concerns. 13, 14 We hypothesized that extremely preterm birth is associated with an increased risk of clinically important reductions in lung function and altered lung mechanics at early school age. The primary aim of the current study was therefore to determine lung function, before and after pharmacological bronchodilation, in a population-based cohort of 6½-year-old children born extremely preterm. We also investigated three readily available neonatal predictors of later lung function by assessing the associations between gestational age at birth, smallness for gestational age at birth and grades of neonatal bronchopulmonary dysplasia, to childhood lung function. Finally, we aimed to assess the proportions of children born extremely preterm with lung function below the lower limit of normal and proportions with ongoing respiratory symptoms. have previously been reported. 1, 4, 6 All EXPRESS-children in three out of the seven Swedish health care regions (n = 250, 51% of the total cohort) were invited to a followup study on lung function at 6½-years-of-age (±3 months). Exclusion criteria were congenital cardiovascular or pulmonary malformations. In 27 cases, the date for inclusion was passed, seven families were lost to follow-up (no address or residing outside Sweden) and 38 declined participation, leaving 178 (71% inclusion rate) children born extremely preterm that participated in the study ( Figure 1 ).
Dropout analyses did not show any significant difference in mean gestational age (participants = 25.0 vs non-participants = 25.3 weeks, P = 0.13), mean birth weight (782 vs 769 g, P = 0.15) or sex distribution (45 vs 50% girls, P = 0.39) between those participating in the study and those lost to follow-up.
Using the Swedish Medical Birth Register, each preterm child was matched to a healthy control born at term (controls; gestational age 37-41 weeks). A list of 10 control children matched on the motherścountry of birth, date of delivery, hospital of birth, and sex was randomly selected. The first child on the list was invited to the study. If participation was declined the next control on the list was approached. If participation was declined for all 10 on the list, the control was considered as missing (n = 6).
| Definitions
Gestational age was determined by ultrasound during gestational weeks 17-18 in more than 95% of the pregnancies. 1 Small for gestational age (SGA) was defined as a birth weight two standard deviations or more below the mean and appropriate for gestational age (AGA) was defined as birth weight within two standard deviations of the mean according to a Swedish sex and gestational agespecific reference for normal fetal growth. 15 Ninety percent of the infants born preterm suffered from bronchopulmonary dysplasia (BPD) in the neonatal period. BPD was categorized as either moderate (breathing >21% but <30% oxygen) or severe (breathing at least 30% oxygen or positive pressure ventilation) at 36 weeks of postmenstrual age. 16 A significant airway response to an inhaled beta-2-agonist (400 mg salbutamol) was defined as increase in FEV 1 >12%.
A lung function below the lower limit of normal was defined as a zscore less than −1.64 (corresponding to less than the 5th percentile).
Asthma-like-disease was defined as any episode of respiratory wheeze or use of asthma medication (inhaled corticosteroids, beta-2-agonsists, anti-leukotriens) in the last 12 months before follow-up, as reported by the parents at time of clinical examination.
| Clinical and lung function assessments
Appointment for follow-up was deferred to at least 2 weeks following any acute respiratory tract illness.
Information on socioeconomics, current, and past parental smoking habits and current respiratory health and respiratory medications was collected using a questionnaire based on the ISAAC-study. 17 Lung function tests consisted of dynamic spirometry and impulse oscillometry (IOS). The tests were performed using the Jaeger MasterScreen-IOS system (Carefusion Technologies, San Diego, CA, USA). Spirometry was performed according to ATS/ERS criteria. 18 The test subject performed at least three maximum expiratory flow volume recordings in sitting position, wearing a nose clip. The highest values of forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV 1 )
were extracted and used for analysis, provided that the subject's effort was coded as being maximal by the test leader, the curve passed visual quality inspection, and that the two highest FVC and FEV 1 readings were reproducible.
The IOS system has previously been described in detail. 19, 20 Briefly, the IOS system generates small pressure oscillations to the airways by a loudspeaker and the software measures respiratory impedance, which includes the respiratory resistance (R rs ) and respiratory reactance (X rs ). All IOS measurements were performed 
| Statistical methods

| Ethical considerations
All parents and children invited to participate received oral and written information, and provided signed informed consent to the study. Study approval was obtained from the Regional Ethical Review Board in Stockholm (no. 2010/520-31/2 and amendment no. 2011/376-32).
| RESULTS
The success rates were 87% for IOS and 54% for spirometry and did not differ between children born extremely preterm and children born at term. In total, 89% of the children contributed with any lung function assessment data ( Figure 1 ). Parental, perinatal and current characteristics of participants contributing with lung function data are presented in Table 1 .
| Lung function in children born extremely preterm
Adjusted lung function estimates and mean group differences are presented in Table 2 (for crude values, please see supplemental-online Table S1 ). The adjusted FVC was 9% lower and the adjusted FEV 1 was 13% lower in children born extremely preterm than in children born at term. IOS measurements showed significantly higher peripheral airway resistance (R 5 and R [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ) and larger area under reactance curve (AX) in children born extremely preterm than in children born at term.
No child in the term control group had FVC or FEV 1 z-score below the lower limit of normal (5th percentile). In the preterm group, the corresponding proportion for FVC was 14%, and for FEV 1 23%.
| Reported respiratory symptoms
Asthma-like disease was reported to be almost three times more prevalent in children born extremely preterm than in control children 
| Bronchodilator responses
Post-bronchodilator FEV 1 could be assessed in 60 (67%) of children born extremely preterm and in 70 (71%) of term children. A significant airway response to the beta2-agonist was seen in 28% of children born extremely preterm and in 10% of controls (P = 0.007). T The post bronchodilator FEV 1 z-score was on average 1.0 (95%CI: −1.33; −0.67) lower in children born extremely preterm than in children born at term.
| Gestational age and lung function in children born extremely preterm
Adjusted lung function estimates and mean group differences are presented in Table 3 (for crude values, please see supplemental-on-line Table S1 ). Children born at 22-24 weeks had 10% lower FVC and 15%
lower FEV 1 than children born at 25-26 weeks of gestation (P = 0.008 and <0.001, respectively). The proportion of children born at [22] [23] [24] weeks with lung function below the lower limit of normal was 24% for FVC and 44% for FEV 1 , corresponding to 5-10 times higher risk of a lung function below normal than controls born at term. The proportions for children born at 25-26 weeks of gestation were 11% and 15%, respectively. IOS measurements did not differ significantly between the two gestational age groups.
| Lung function in children born extremely preterm and SGA
Adjusted lung function estimates and mean group differences are presented in Table 4 (for crude values, please see supplemental-on-line Table S1 ). Fourteen percent of the children born extremely preterm had a birth weight which was outside the expected range, that is, small for gestational age, SGA. Spirometry outcomes in children born extremely preterm did not differ significantly between those born SGA and those born AGA. However, children born SGA had higher R [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] assessed with IOS than those born AGA.
| Severity of BPD and later lung function
Adjusted lung function estimates and mean group differences are presented in Table 5 (for crude values, please see supplemental-on-line Table S1 ). In children born extremely preterm, 76% were diagnosed with moderate and 14% with severe BPD in the neonatal period.
Significant difference in lung function in relation to severity of BPD was only seen for the FEV 1 /FVC ratio, which was lower (−0.73 zscores, 95%CI −1.36;−0.10, P 0.02) in children with severe compared to moderate BPD.
| DISCUSSION
In this population-based follow-up study we found that extremely preterm birth was associated with reduced lung function at 6½-years- found, z-score −1.13 for FEV 1 . Also in line with our study, Simpson et al showed reductions of −1.06 z-score FEV 1 for the BPD group, which is comparable regarding gestational age to our study. 13 Vergheggen et al found somewhat less reduced FEV 1 (−0.59 zscore), but the BPD group in that study included less immature children then our study which could explain the difference. 14 Z-scores for healthy subjects have been calculated for the IOS outcome variables AX and R [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] in Finnish and Mexican children. 26, 27 Depending on which reference used in the calculations, we found that the mean z-score for AX (before reversibility test) among healthy 6½-year-old children participating in our study (those with asthma reductions of 16% associated with mild BPD and 19% for moderate to severe BPD. 29 The modest or non-significant differences in lung function related to degree of BPD found by us and others indicate that childhood respiratory dysfunction can essentially be related to gestational age, and that BPD classification seems to be of limited value for predicting future lung function measured by spirometry. | 69
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In extremely preterm children born SGA, the IOS variable R [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] (indicator of airway obstruction) was slightly higher compared to children born AGA, while no the differences were found in spirometry measures. Others have-independent of gestational age-found a link between low birth weight and reduced lung function assessed with spirometry in infancy and at school age. 
| Strengths and limitations
Major strengths of this study include the population-based, prospective design and the follow-up time. Follow-up rate was 71% and dropout analysis did not indicate any response bias. The study was controlled by design and the control group was carefully chosen to avoid selection bias. All results were adjusted for current height, sex, and investigation site, and any interaction between sex and extremely preterm birth was excluded. The outcomes, spirometry in particular, were clinically highly relevant.
We note that our control group of children born at term exhibited approximately 0.5 higher z-score for spirometry outcomes than the published reference population (GLI). 21 If anything, this may suggest an underestimation of the frequency of children born extremely preterm with a lung function below the lower limit of normal, but is not likely to affect differences seen between groups.
Limitations include that those performing the measurements were not blinded. To minimize observer bias, strict predefined criteria for quality control and analysis of recordings were used, and all measurements were controlled for accuracy by a single technician.
The success rate for spirometry was low, but anticipated because of the young age at follow-up, but could introduce a selection bias.
However, since there was no difference in success rate between children born extremely preterm and controls born at term it is likely to be non-differential. We did not perform measurements of total lung capacity and could therefore not deduce whether the reduced FVC seen in the preterm group reflected a restrictive lung impairment or hyperinflation as a marker of more severe obstructive lung disease, or both. Our questionnaire on respiratory symptoms was based on questions initially developed for studies on asthma-related outcomes and not for outcomes related to preterm birth. 36 Asthma and chronic lung disease after preterm birth have some clinical and physiological features in common, but may differ in other respects such as presence or absence of airway inflammation. We used the term asthma-like disease since the term asthma should be avoided in describing pulmonary problems following preterm birth. 37 
| Clinical aspects of the results
It has been established that preterm birth increases the risk of chronic respiratory morbidity, including asthma-like disease during childhood and later on in life. [38] [39] [40] There is however, still a lack of knowledge about the prevalence and magnitude of chronic respiratory morbidity after extremely preterm birth. We find it deeply concerning that asthma-like disease was very prevalent among children born extremely preterm and that up to half of the children born at 22-24 weeks of gestation exhibited a lung function below the lower limits of normal.
How these findings translate into quality of life for these children and their families remain to be clarified.
Previous assessments of reversibility of bronchial obstruction in children born preterm have shown varying results. 12, 30, 41, 42 We found that one quarter of children born extremely preterm responded positively to pharmacological bronchodilation, implying a therapeutic way forward. 21 Nevertheless, the post bronchodilator FEV 1 was still significantly lower in the preterm group than in controls (data not shown), indicating only partially reversible airways. Accordingly, non-reversible airway obstruction remains as significant problem after extremely preterm birth. Institute. The funding organizations had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The funding sources had no role in planning, conducting or the interpretation of this study.
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